NCT00002919View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 1996

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

doxorubicin hydrochloride

DRUG

methotrexate

DRUG

vinblastine sulfate

PROCEDURE

conventional surgery

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002919 - Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer | Biotech Hunter | Biotech Hunter